The Food and Drug Administration authorized a tobacco-flavored e-cigarette made by Reynolds American and denied authorization for fruit-flavored refill cartridges, signaling its approach to sweet and fruity e-cigarette flavors that are popular among teens
The Food and Drug Administration on Tuesday authorized a tobacco-flavored e-cigarette made by tobacco giant Reynolds American Inc. and rejected several fruit-flavored refill cartridges the company wanted to bring back on the market.
The decision signals the hard line the agency is taking on sweet and fruity e-cigarette flavors in a broad review it is conducting to determine which vaping products may remain on the U.S. market. Reynolds’ Vuse Solo vaporizer and its tobacco-flavored refill cartridges are the first products to receive authorization as part of the review.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA authorizes first e-cigarettes, cites benefit for smokersHeath officials on Tuesday authorized the first electronic cigarettes in the U.S., saying the R.J. Reynolds vaping products can benefit adult smokers. The Food and Drug Administration said data submitted by the company showed its Vuse e-cigarettes helped smokers either quit or significantly reduce their use of cigarettes, the leading preventable cause of death in the U.S. Tuesday’s first-of-a-kind decision is part of a sweeping effort by the FDA to bring scientific scrutiny to the multibillion-dollar vaping industry after years of delays.
Read more »
Merck COVID pill vs. ivermectin: What to know about approval, effectiveness, usageMerck's oral antiviral could become the first FDA-authorized outpatient therapeutic that doesn't require a health care professional to administer.
Read more »
U.S. moves closer to clearing Moderna and J&J Covid booster shots this weekThe FDA's vaccine advisory committee meeting come less than a month after U.S. regulators authorized third Covid shots of Pfizer's vaccine.
Read more »
Merck asks the FDA to authorize use of its promising COVID-19 pillDrugmaker Merck has asked U.S. regulators to authorize its promising pill protecting against COVID-19, setting the stage for a decision within weeks.
Read more »
Merck asks FDA to authorize antiviral Covid pill for emergency useMerck has asked the FDA to authorize its antiviral Covid pill for emergency use. ScottGottliebMD weighs in: 'I think where the government misstepped is that we didn't invest enough in trying to scale up the manufacturing of therapeutics across the board.'
Read more »